Skip to main content

Taysha Gene Therapies, Inc.

TSHA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001806310

In the last 90 days, Taysha Gene Therapies, Inc. insiders filed 0 open-market purchases and 1 sale; 208 institutions reported holding it in 13F filings for Q2 2026, worth $2.03B in total; no superinvestor holds it.

13F holders, Q1 2025

Institutional positions in Taysha Gene Therapies, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
127
−3 vs. Q4 2024
Shares held
166.9M
−74.2K (0.0%) vs. Q4 2024
Total value
$232.0M
−$56.8M (−19.7%) vs. Q4 2024
New holders
22
38 more added
Sold out
25
31 more reduced

1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting TSHA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2025: 127 institutions
Q1 2021: 46 institutionsQ2 2021: 49 institutionsQ3 2021: 48 institutionsQ4 2021: 65 institutionsQ1 2022: 71 institutionsQ2 2022: 59 institutionsQ3 2022: 54 institutionsQ4 2022: 52 institutionsQ1 2023: 44 institutionsQ2 2023: 39 institutionsQ3 2023: 63 institutionsQ4 2023: 87 institutionsQ1 2024: 109 institutionsQ2 2024: 107 institutionsQ3 2024: 119 institutionsQ4 2024: 131 institutionsQ1 2025: 127 institutionsQ2 2025: 150 institutionsQ3 2025: 155 institutionsQ4 2025: 195 institutionsQ1 2026: 191 institutionsQ2 2026: 208 institutions
Value heldQ1 2025: $232.0M
Q1 2021: $358.5MQ2 2021: $388.6MQ3 2021: $361.9MQ4 2021: $215.6MQ1 2022: $110.9MQ2 2022: $54.7MQ3 2022: $27.0MQ4 2022: $43.8MQ1 2023: $13.3MQ2 2023: $9.05MQ3 2023: $410.6MQ4 2023: $230.3MQ1 2024: $402.2MQ2 2024: $354.3MQ3 2024: $315.5MQ4 2024: $289.8MQ1 2025: $232.0MQ2 2025: $595.4MQ3 2025: $865.6MQ4 2025: $1.48BQ1 2026: $1.18BQ2 2026: $2.03B
Institutions holding TSHA and their total value by quarter
QuarterHoldersValue
Q2 2026208$2.03B
Q1 2026191$1.18B
Q4 2025195$1.48B
Q3 2025155$865.6M
Q2 2025150$595.4M
Q1 2025127$232.0M
Q4 2024131$289.8M
Q3 2024119$315.5M
Q2 2024107$354.3M
Q1 2024109$402.2M
Q4 202387$230.3M
Q3 202363$410.6M
Q2 202339$9.05M
Q1 202344$13.3M
Q4 202252$43.8M
Q3 202254$27.0M
Q2 202259$54.7M
Q1 202271$110.9M
Q4 202165$215.6M
Q3 202148$361.9M
Q2 202149$388.6M
Q1 202146$358.5M

Institutions, Q1 2025

Shares, value and share of portfolio for each institution holding Taysha Gene Therapies, Inc.; share changes are against Q4 2024.

Institutions holding TSHA in Q1 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Barclays PLC708,966$985.5K0.00%+373,728+111.5%Added
Sands Capital Ventures, LLC724,873$1.01M0.25%00.0%Unchanged
Superstring Capital Management LP755,599$1.05M1.25%+755,599New
Quantum Private Wealth, LLC791,476$1.10M0.42%−3,500−0.4%Reduced
Woodline Partners LP858,254$1.19M0.01%−169,268−16.5%Reduced
JPMorgan Chase & Co1,003,067$1.39M0.00%−1,640,688−62.1%Reduced
ADAR1 Capital Management, LLC1,066,309$1.48M0.29%+888,602+500.0%Added
B Group, Inc.1,255,556$1.75M1.52%+290,000+30.0%Added
Palo Alto Investors LP1,419,468$1.97M0.38%+608,200+75.0%Added
Northern Trust Corp1,431,666$1.99M0.00%−27,066−1.9%Reduced
Granahan Investment Management Inc1,640,793$2.28M0.11%+4,412+0.3%Added
Millennium Management LLC1,772,654$2.46M0.00%+1,621,040+1,069.2%Added
Polar Capital Holdings Plc3,000,000$4.17M0.03%00.0%Unchanged
State Street Corp3,233,512$4.49M0.00%−3,240,855−50.1%Reduced
Geode Capital Management, LLC3,664,732$5.10M0.00%+92,383+2.6%Added
Tybourne Capital Management (HK) Ltd3,700,000$5.14M21.83%00.0%Unchanged
Baker Bros. Advisors LP4,004,756$5.57M0.06%00.0%Unchanged
Point72 Asset Management, L.P.4,569,678$6.35M0.02%+4,569,678New
Siren, L.L.C.6,514,737$9.06M0.51%−87,738−1.3%Reduced
Vanguard Group Inc8,770,921$12.2M0.00%−135,843−1.5%Reduced
Octagon Capital Advisors LP10,700,000$14.9M3.23%+250,000+2.4%Added
Ra Capital Management, L.P.10,872,503$15.1M0.25%00.0%Unchanged
BlackRock, Inc.13,589,178$18.9M0.00%+57,711+0.4%Added
FMR LLC15,631,954$21.7M0.00%−733,710−4.5%Reduced
Morgan Stanley16,846,374$23.4M0.00%−793,992−4.5%Reduced
RTW Investments, LP18,787,866$26.1M0.40%+10,115,236+116.6%Added
Avoro Capital Advisors LLC19,999,999$27.8M0.43%00.0%Unchanged
Adage Capital Partners GP, L.L.C.0$00.00%−5,000,000−100.0%Sold out
VR Adviser, LLC0$00.00%−3,225,180−100.0%Sold out
Norges Bank0$00.00%−1,461,120−100.0%Sold out
Acuta Capital Partners, LLC0$00.00%−884,244−100.0%Sold out
Renaissance Technologies LLC0$00.00%−878,448−100.0%Sold out
Rafferty Asset Management, LLC0$00.00%−252,257−100.0%Sold out
Squarepoint Ops LLC0$00.00%−211,842−100.0%Sold out
Jane Street Group, LLC0$00.00%−169,575−100.0%Sold out
Marshall Wace, LLP0$00.00%−138,111−100.0%Sold out
Virtu Financial LLC0$00.00%−107,544−100.0%Sold out
Aquatic Capital Management LLC0$00.00%−78,246−100.0%Sold out
LPL Financial LLC0$00.00%−60,000−100.0%Sold out
Profund Advisors LLC0$00.00%−50,242−100.0%Sold out
Engineers Gate Manager LP0$00.00%−35,808−100.0%Sold out
Verition Fund Management LLC0$00.00%−34,098−100.0%Sold out
Virtus ETF Advisers LLC0$00.00%−31,597−100.0%Sold out
SG Americas Securities, LLC0$00.00%−28,498−100.0%Sold out
Axq Capital, LP0$00.00%−22,432−100.0%Sold out
E Fund Management Co., Ltd.0$00.00%−17,844−100.0%Sold out
Ground Swell Capital, LLC0$00.00%−14,660−100.0%Sold out
Two Sigma Investments, LP0$00.00%−12,300−100.0%Sold out
Skopos Labs, Inc.0$00.00%−4,500−100.0%Sold out
Rothschild Investment LLC0$00.00%−130−100.0%Sold out
R Squared Ltd0$00.00%−130−100.0%Sold out
Lazard Asset Management LLC0$00.00%−154−100.0%Sold out
Nuveen Asset Management, LLC––––Not filed